Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation

被引:58
|
作者
Zhang, Jie [1 ]
He, Pengxing [2 ]
Xi, Yong [1 ]
Geng, Meiyu [1 ]
Chen, Yi [1 ]
Ding, Jian [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
[2] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
colorectal cancer; G9a; epigenetics; DNA damage response (DDR); SN38/CPT; synergistic effect; CURATIVE RESECTION; METHYLTRANSFERASE; METHYLATION; INSTABILITY; EXPRESSION; REPAIR;
D O I
10.18632/oncotarget.2784
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
G9a, a histone methyltransferase, is aberrantly expressed in some human tumor types. By comparing 182 paired colorectal cancer and peritumoral tissues, we found that G9a was highly expressed in colorectal cancer (CRC). Overexpression of G9a promoted CRC cells proliferation and colony formation, whereas knockdown of G9a inhibited CRC cells proliferation. Depletion of G9a increased the rate of chromosome aberration, induced DNA double strand breaks and CRC cells senescence. G9a inhibition synergistically increased gamma H2AX expression induced by topoisomerase I inhibitors and ultimately led to CRC cell death. The findings that down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation may define G9a as potential oncotarget in CRC.
引用
下载
收藏
页码:2917 / +
页数:13
相关论文
共 50 条
  • [1] Down-regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells
    Li, Jun
    Yu, Liang
    Zhang, Huizhong
    Wu, Jueheng
    Yuan, Jie
    Li, Xiaoxi
    Li, Mengfeng
    CANCER SCIENCE, 2009, 100 (12) : 2255 - 2260
  • [2] Skullcapflavone I inhibits proliferation of human colorectal cancer cells via down-regulation of miR-107 expression
    Zhang, W.
    Li, W.
    Han, X.
    NEOPLASMA, 2019, 66 (02) : 203 - 210
  • [3] Down-regulation of FRα Inhibits Proliferation and Promotes Apoptosis of Cervical Cancer Cells in Vitro
    Bai, Li-Xia
    Ding, Ling
    Jiang, Shi-Wen
    Kang, Hui-Jie
    Gao, Chen-Fei
    Chen, Chen
    Zhou, Qin
    Wang, Jin-Tao
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5667 - 5672
  • [4] STATIN INHIBITS THE PROLIFERATION OF HUMAN PROSTATE CANCER CELLS VIA DOWN-REGULATION OF THE SURVIVIN
    Koike, H.
    Sekine, Y.
    Furuya, Y.
    Morikawa, Y.
    Matsui, H.
    Shibata, Y.
    Suzuki, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 273 - 273
  • [5] Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α
    Jang, Soon Young
    Kim, Jiyun
    Hong, Eunbi
    Yang, Yoon Jung
    Na, Yuran
    Yeom, Chang-Hwan
    Park, Seyeon
    ANTICANCER RESEARCH, 2024, 44 (03) : 1109 - 1120
  • [6] Down-regulation of RFWD3 inhibits cancer cells proliferation and migration in gastric carcinoma
    Jia, Jia
    Yang, Yanguo
    Yan, Tingting
    Chen, Tao
    Lu, Guangxin
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2020, 39 (04) : 363 - 371
  • [7] Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions
    Raynaud, C. M.
    Jang, S. J.
    Nuciforo, P.
    Lantuejoul, S.
    Brambilla, E.
    Mounier, N.
    Olaussen, K. A.
    Andre, F.
    Morat, L.
    Sabatier, L.
    Soria, J. -C.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1875 - 1881
  • [8] Down-regulation of AQP4 Inhibits Proliferation, Migration and Invasion of Human Breast Cancer Cells
    Li, Y-B.
    Sun, S-R.
    Han, X-H.
    FOLIA BIOLOGICA, 2016, 62 (03) : 131 - 137
  • [9] Crocetin treatment inhibits proliferation of colon cancer cells through down-regulation of genes involved in the inflammation
    Zhuang, Xinying
    Dong, Aihua
    Wang, Ruicai
    Shi, Aijian
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2018, 25 (08) : 1767 - 1771
  • [10] Down-regulation of tripartite motif protein 59 inhibits proliferation, migration and invasion in breast cancer cells
    Zhang, Yan
    Yang, Wen-Bin
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 462 - 467